Commercial leaders vs. other companies in U.S. biotech 2016
This statistic depicts a comparison of commercial leaders vs. other companies in U.S. biotechnology in 2016. In that year, the revenues of commercial leaders amounted to around 99 billion U.S. dollars, while the revenues of other companies in this sector came to some 13.4 billion U.S. dollars.
